Guardian Pharmacy Services (NYSE:GRDN) Shares Down 5.1% - Should You Sell?

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s stock price was down 5.1% on Monday . The stock traded as low as $21.00 and last traded at $21.71. Approximately 41,175 shares were traded during trading, a decline of 73% from the average daily volume of 154,192 shares. The stock had previously closed at $22.87.

Analyst Ratings Changes

Separately, Truist Financial raised their price objective on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, April 11th.

Guardian Pharmacy Services Trading Up 2.6 %

The company has a fifty day moving average of $20.64 and a two-hundred day moving average of $20.82.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in GRDN. Envestnet Asset Management Inc. raised its stake in shares of Guardian Pharmacy Services by 4.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company's stock worth $243,000 after buying an additional 564 shares in the last quarter. LPL Financial LLC lifted its holdings in Guardian Pharmacy Services by 4.8% in the fourth quarter. LPL Financial LLC now owns 17,679 shares of the company's stock valued at $358,000 after acquiring an additional 807 shares during the period. GAMMA Investing LLC acquired a new position in shares of Guardian Pharmacy Services during the 1st quarter worth $170,000. Lazard Asset Management LLC increased its holdings in shares of Guardian Pharmacy Services by 0.5% in the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock valued at $3,865,000 after purchasing an additional 860 shares in the last quarter. Finally, R Squared Ltd acquired a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at about $30,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.